| RS2102636068 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102636076 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS2102636085 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102637431 |
IL23R
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2102637875 |
LMX1A
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 7, Autosomal dominant nonsyndromic hearing loss 7 |
| RS2102638530 |
FBXO28
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 100, Developmental and epileptic encephalopathy 100 |
| RS2102638590 |
FBXO28
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 100, Developmental and epileptic encephalopathy 100 |
| RS2102638612 |
FBXO28
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 100, Developmental and epileptic encephalopathy 100 |
| RS2102638625 |
FBXO28
|
Health Risk |
Likely pathogenic |
— |
| RS2102638631 |
FBXO28
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 100, Developmental and epileptic encephalopathy 100 |
| RS2102639360 |
DARS2
|
Health Risk |
Likely pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS2102640989 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102641279 |
DARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome, Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome |
| RS2102642087 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102643165 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102643210 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102644733 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102644788 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102644805 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102644832 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS2102644857 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102647752 |
NUAK2
|
Health Risk |
Pathogenic |
Anencephaly 2, Anencephaly 2 |
| RS2102650567 |
DEGS1
|
Health Risk |
Likely pathogenic |
— |
| RS2102650681 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102651720 |
PAPPA2
|
Health Risk |
Pathogenic |
Short stature, Dauber-Argente type |
| RS2102654383 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102655189 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102655666 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102655700 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2102655719 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102655994 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102656066 |
DEGS1
|
Health Risk |
Pathogenic |
— |
| RS2102656270 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102656326 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, USH2A-related disorder |
| RS2102658561 |
DEGS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leukodystrophy, hypomyelinating |
| RS2102658759 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102658764 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinitis pigmentosa 39 |
| RS2102658767 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS2102658827 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102661156 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102661164 |
USH2A
|
Health Risk |
Pathogenic |
USH2A-related disorder, USH2A-related disorder |
| RS2102661189 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102661201 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102661317 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome, Retinitis pigmentosa 39 |
| RS2102661344 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102661452 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102664474 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102664776 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102664808 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102664886 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102664921 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102665272 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102665279 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102665314 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102665328 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102665356 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102665385 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2102665496 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102665526 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102665766 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102665930 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102665932 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102666136 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102666300 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102666433 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102666781 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102666887 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102667066 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2102667069 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102671641 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102671802 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102672664 |
PYCR2
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 10, Hypomyelinating leukodystrophy 10 |
| RS2102672881 |
PYCR2
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 10, Hypomyelinating leukodystrophy 10 |
| RS2102672892 |
PYCR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypomyelinating leukodystrophy 10, Hypomyelinating leukodystrophy 10 |
| RS2102676931 |
SNX27
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2102681464 |
SNX27
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2102682130 |
CACNA1E
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 69 |
| RS2102689621 |
CACNA1E
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2102689660 |
CACNA1E
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2102690228 |
SNX27
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2102708440 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102708663 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2102713275 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2102713360 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102713573 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102713621 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102713688 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102713705 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS2102713794 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2102718189 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
CACNA1E-related disorder, CACNA1E-related disorder |
| RS2102723150 |
CACNA1E
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2102724265 |
SNX27
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS2102725799 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2102727387 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2102727580 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2102735014 |
ACTA1
|
Health Risk |
Likely pathogenic |
ACTA1-related myopathies, ACTA1-related myopathies |
| RS2102735031 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2102735038 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Alpha-actinopathy |
| RS2102735175 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS2102735270 |
ACTA1
|
Health Risk |
Pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |